NEW YORK, August 14, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding Intuitive Surgical, Inc. (NASDAQ: ISRG), InterMune, Inc. (NASDAQ: ITMN), Precision Castparts Corp. (NYSE: PCP), Exelon Corporation (NYSE: EXC) and Duke Energy Corporation (NYSE: DUK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5733-100free.
--
Intuitive Surgical, Inc. Research Reports
According to Intuitive Surgical, Inc.'s (Intuitive Surgical) Investor Relations section, the Company will participate in the Morgan Stanley Healthcare Conference to be held on September 10, 2014 at 8:35 a.m. ET in New York, U.S. The full research reports on Intuitive Surgical are available to download free of charge at:
http://www.analystsreview.com/Aug-14-2014/ISRG/report.pdf
--
InterMune, Inc. Research Reports
On August 6, 2014, InterMune, Inc. (InterMune) announced its Q2 2014 financial results. The Company reported 148.2% YoY increase in Q2 2014 net revenues to $35.7 million from the sales of Esbriet -- InterMune's product for the treatment of idiopathic pulmonary fibrosis (IPF) in adults. However, weighed down by sharp rise in research and development (R&D) expenses as well as selling, general and administrative (SG&A) expenses, the Company's net loss during the quarter widened to $71.2 million from $62.9 million in Q2 2013. InterMune's R&D expenses increased 44.4% YoY, and SG&A expenses rose 41.2% YoY during the quarter. InterMune now expects full-year 2014 revenue towards the higher end of its previously provided guidance range of $130-$140 million. The Company has also raised its full-year 2014 R&D and SG&A expense forecast ranges to $130 to $140 million (previously $110 to $120 million) and $250 to $260 million (previously $210 to $225 million), respectively. The full research reports on InterMune are available to download free of charge at:
http://www.analystsreview.com/Aug-14-2014/ITMN/report.pdf
--
Precision Castparts Corp. Research Reports
On August 11, 2014, the stock of Precision Castparts Corp. (Precision Castparts) declined 0.02% to end the trading session at $233.78. During the session, the Company's stock opened at $233.64, and fluctuated in the range of $233.51 - $236.18, with a total of 0.76 million shares changing hands. Over the last one month, the stock of Precision Castparts has declined 8.61%, compared to the Dow Jones Industrial Average, which declined by 2.21% during the same period. The full research reports on Precision Castparts are available to download free of charge at:
http://www.analystsreview.com/Aug-14-2014/PCP/report.pdf
--
Exelon Corporation Research Reports
On August 6, 2014, Exelon Corporation (Exelon) reported that its LaSalle Generating Station Unit 2 automatically shut down at 5:34 p.m. on August 5, 2014, after the closure of a valve on one of the station's steam lines. The Company stated that there was no incident due to the plant shut down and the operators have been looking into the cause of valve closure. Exelon stated that the LaSalle Unit 2 shutdown will not have an impact on electrical service to Exelon customers since Unit 1 is operating at full power. The full research reports on Exelon are available to download free of charge at:
http://www.analystsreview.com/Aug-14-2014/EXC/report.pdf
--
Duke Energy Corporation Research Reports
On August 7, 2014, Duke Energy Corporation (Duke Energy) announced its Q2 2014 financial results. Net income attributable to Duke Energy increased to $609 million, or $0.86 per diluted share, from $339 million, or $0.48 per diluted share, in Q2 2013. On an adjusted basis, the Company reported diluted EPS of $1.11, beating the average forecast of $0.98 in a Reuters' poll of analysts. The Company's total operating revenues during the quarter increased 1.2% YoY to $5.9 billion. Duke Energy said it witnessed strong performance from all of its business units in the quarter as Regulated Utilities continued to benefit from favorable weather and a lower effective tax rate, while International Energy recognized a tax benefit resulting from reorganization of the Company's operations in Chile. The Company has increased its full-year 2014 adjusted EPS guidance range to $4.50 to $4.65 from $4.45 to $4.60 forecasted earlier. The full research reports on Duke Energy are available todownload free of charge at:
http://www.analystsreview.com/Aug-14-2014/DUK/report.pdf
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
AnalystsReview.com
SOURCE Analysts Review
